Moderna's vaccine maker identifies the 'big challenges' to mass producing the coronavirus vaccine

Manufacturing sites, skilled personnel and temperature control — just some of the challenges facing vaccine makers now.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.